NASDAQ · BIB

ProShares Ultra NASDAQ Biotechnology news

$115.63+1.06%

Close Sep 28, 2026 · split-adjusted

Articles · 30 days0English, de-duplicated

Positive0

Neutral0

Negative0

About ProShares Ultra NASDAQ Biotechnology

No recent articles focused on ProShares Ultra NASDAQ Biotechnology.

Also mentions BIB

Articles that tag BIB but are mainly about other companies.

None recently.

Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology